Literature DB >> 25260254

A tripartite cocktail of chimeric monoclonal antibodies passively protects mice against ricin, staphylococcal enterotoxin B and Clostridium perfringens epsilon toxin.

Erin K Sully1, Kevin Whaley2, Natasha Bohorova2, Ognian Bohorov2, Charles Goodman2, Do Kim2, Michael Pauly2, Jesus Velasco2, Frederick W Holtsberg3, Eric Stavale3, M Javad Aman3, Chandra Tangudu4, Francisco A Uzal5, Nicholas J Mantis6, Larry Zeitlin7.   

Abstract

Due to the fast-acting nature of ricin, staphylococcal enterotoxin B (SEB), and Clostridium perfringens epsilon toxin (ETX), it is necessary that therapeutic interventions following a bioterrorism incident by one of these toxins occur as soon as possible after intoxication. Moreover, because the clinical manifestations of intoxication by these agents are likely to be indistinguishable from each other, especially following aerosol exposure, we have developed a cocktail of chimeric monoclonal antibodies that is capable of neutralizing all three toxins. The efficacy of this cocktail was demonstrated in mouse models of lethal dose toxin challenge.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibody; Biodefense; Therapeutic; Toxin

Mesh:

Substances:

Year:  2014        PMID: 25260254      PMCID: PMC4248019          DOI: 10.1016/j.toxicon.2014.09.006

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  23 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

Review 2.  Vaccines against the category B toxins: Staphylococcal enterotoxin B, epsilon toxin and ricin.

Authors:  Nicholas J Mantis
Journal:  Adv Drug Deliv Rev       Date:  2005-06-17       Impact factor: 15.470

3.  Prevention and treatment of Clostridium perfringens epsilon toxin intoxication in mice with a neutralizing monoclonal antibody (c4D7) produced in Nicotiana benthamiana.

Authors:  J P Garcia; J Beingesser; O Bohorov; N Bohorova; C Goodman; D Kim; M Pauly; J Velasco; K Whaley; L Zeitlin; C J Roy; F A Uzal
Journal:  Toxicon       Date:  2014-06-17       Impact factor: 3.033

4.  Chimeric plantibody passively protects mice against aerosolized ricin challenge.

Authors:  Erin K Sully; Kevin J Whaley; Natasha Bohorova; Ognian Bohorov; Charles Goodman; Do H Kim; Michael H Pauly; Jesus Velasco; Ernie Hiatt; Josh Morton; Kelsi Swope; Chad J Roy; Larry Zeitlin; Nicholas J Mantis
Journal:  Clin Vaccine Immunol       Date:  2014-02-26

5.  Development of monoclonal antibodies suitable for use in antigen quantification potency tests for clostridial veterinary vaccines.

Authors:  P J Hauer; N E Clough
Journal:  Dev Biol Stand       Date:  1999

6.  Enhanced antibody half-life improves in vivo activity.

Authors:  Jonathan Zalevsky; Aaron K Chamberlain; Holly M Horton; Sher Karki; Irene W L Leung; Thomas J Sproule; Greg A Lazar; Derry C Roopenian; John R Desjarlais
Journal:  Nat Biotechnol       Date:  2010-01-17       Impact factor: 54.908

7.  Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure.

Authors:  Richard Strasser; Johannes Stadlmann; Matthias Schähs; Gabriela Stiegler; Heribert Quendler; Lukas Mach; Josef Glössl; Koen Weterings; Martin Pabst; Herta Steinkellner
Journal:  Plant Biotechnol J       Date:  2008-03-13       Impact factor: 9.803

8.  A novel investigational Fc-modified humanized monoclonal antibody, motavizumab-YTE, has an extended half-life in healthy adults.

Authors:  Gabriel J Robbie; Ryan Criste; William F Dall'acqua; Kathryn Jensen; Nita K Patel; Genevieve A Losonsky; M Pamela Griffin
Journal:  Antimicrob Agents Chemother       Date:  2013-09-30       Impact factor: 5.191

Review 9.  The staphylococcal enterotoxin (SE) family: SEB and siblings.

Authors:  Teresa Krakauer; Bradley G Stiles
Journal:  Virulence       Date:  2013-04-19       Impact factor: 5.882

Review 10.  Mucosal vaccines for biodefense.

Authors:  N J Mantis; L A Morici; C J Roy
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

View more
  6 in total

1.  Mechanisms of Ricin Toxin Neutralization Revealed through Engineered Homodimeric and Heterodimeric Camelid Antibodies.

Authors:  Cristina Herrera; Jacqueline M Tremblay; Charles B Shoemaker; Nicholas J Mantis
Journal:  J Biol Chem       Date:  2015-09-22       Impact factor: 5.157

2.  Humanized Monoclonal Antibody That Passively Protects Mice against Systemic and Intranasal Ricin Toxin Challenge.

Authors:  Greta Van Slyke; Erin K Sully; Natasha Bohorova; Ognian Bohorov; Do Kim; Michael H Pauly; Kevin J Whaley; Larry Zeitlin; Nicholas J Mantis
Journal:  Clin Vaccine Immunol       Date:  2016-09-06

3.  A Bispecific Antibody Promotes Aggregation of Ricin Toxin on Cell Surfaces and Alters Dynamics of Toxin Internalization and Trafficking.

Authors:  Cristina Herrera; Tove Irene Klokk; Richard Cole; Kirsten Sandvig; Nicholas J Mantis
Journal:  PLoS One       Date:  2016-06-14       Impact factor: 3.240

4.  Versatile and on-demand biologics co-production in yeast.

Authors:  Jicong Cao; Pablo Perez-Pinera; Ky Lowenhaupt; Ming-Ru Wu; Oliver Purcell; Cesar de la Fuente-Nunez; Timothy K Lu
Journal:  Nat Commun       Date:  2018-01-08       Impact factor: 14.919

5.  Highly sensitive sandwich immunoassay and immunochromatographic test for the detection of Clostridial epsilon toxin in complex matrices.

Authors:  Cécile Féraudet-Tarisse; Christelle Mazuet; Serge Pauillac; Maren Krüger; Caroline Lacroux; Michel R Popoff; Brigitte G Dorner; Olivier Andréoletti; Marc Plaisance; Hervé Volland; Stéphanie Simon
Journal:  PLoS One       Date:  2017-07-11       Impact factor: 3.240

6.  Effective Treatment of Staphylococcal Enterotoxin B Aerosol Intoxication in Rhesus Macaques by Using Two Parenterally Administered High-Affinity Monoclonal Antibodies.

Authors:  Daniel Verreault; Jane Ennis; Kevin Whaley; Stephanie Z Killeen; Hatice Karauzum; M Javad Aman; Rick Holtsberg; Lara Doyle-Meyers; Peter J Didier; Larry Zeitlin; Chad J Roy
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.